Cargando…
贝伐珠单抗联合培美曲塞加卡铂新辅助化疗方案对Ⅲa期肺腺癌手术安全性的影响
BACKGROUND AND OBJECTIVE: Bevacizumab has showed its efficacy in advanced non-squamous lung cancer. The aim of this study is to assess the safety of bevacizumab plus pemetrexed and carboplatin neoadjuvant chemotherapy in patients with lung adenocarcinoma. METHODS: 25 patients with Ⅲa lung adenocarci...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999904/ https://www.ncbi.nlm.nih.gov/pubmed/26104893 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.06 |
Ejemplares similares
-
培美曲塞联合顺铂或卡铂治疗复发或转移性非小细胞肺癌63例疗效分析
Publicado: (2011) -
贝伐珠单抗联合紫杉醇/卡铂治疗晚期非小细胞肺癌25例分析
Publicado: (2012) -
培美曲塞/顺铂二线治疗晚期非小细胞肺癌:一例报告及文献复习
Publicado: (2010) -
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
Publicado: (2011) -
培美曲赛单药与培美曲赛联合奥沙利铂用于Ⅳ期肺腺癌挽救性治疗的比较
Publicado: (2011)